Josh Pettit

Josh Pettit has over 15 years of work experience in the pharmaceutical and biotech industry. Josh is currently serving as the Vice President of Sales, Ophthalmology at Coherus BioSciences. Prior to this, they operated their own consulting firm, High Hill Consultants LLC, where they provided services to various firms in the field of Ophthalmology, Immunology, and Rare Diseases. Josh also held significant roles at EyePoint Pharmaceuticals, Mallinckrodt Pharmaceuticals, Bausch + Lomb, Novartis, Orthofix, and Boehringer Ingelheim, where they gained extensive experience in sales management and account specialization in areas such as Ophthalmology, Rare Diseases, Spine Surgery, Neurology, and Rheumatology.

Josh Pettit's education history is as follows:

- In 2020, they completed the "CRISPR: Gene Editing Applications" program in Gene Editing and Gene Therapies from Professional & Executive Development - Harvard Division of Continuing Education.

- In the same year, they also participated in the Oxford Executive Leadership Program at Saïd Business School, University of Oxford.

- From 2001 to 2003, they pursued a Master's Degree at the University of London.

- Josh obtained their Bachelor's Degree from Baylor University between 1996 and 2000.

Additionally, they have obtained several certifications, including "Become an Agile Project Manager," "Agile Foundations," "Cert Prep: Project Management Professional (PMP)," "Decision-Making Strategies," "Product Marketing Foundations," "Strategic Partnerships," "Strategic Thinking," and "Transformational Leadership," all from LinkedIn in 2020.